iShares Nasdaq Biotechnology Index Fund | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (105)

Latest Posts

About This Stock More About This Stock
Sunnier Skies This Past Week, But Will It Last?
Article By: Keith Schneider
Sunday, May 21, 2023 8:01 AM EDT
The stock market rallied out of a long sideway consolidation pattern and made a new year-to-date high as well as a positive 52-week period. The S&P 500 was up 1.71%, and the Nasdaq 100 was up 3.53% for the week.
In this article: COPX, IBB, QQQ, DBA, DIA, EEM, EFA, GDX, GLD, IWM, KRE, SLV, SMH, SPY, TLT, VTV, VUG, XLP, XLU, XLY, VIX, VXV, XRT
Read
April Is Busting Out For Healthcare And Biotech
Article By: Rod Raynovich
Monday, April 10, 2023 2:36 PM EDT
Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend.
In this article: UNH, IBB, IHI, IWF, XBI, XLV
Read
Large Cap Biopharmaceuticals Q1 2023: In This Bullish Run Biotech Lags
Article By: Rod Raynovich
Monday, April 3, 2023 1:14 PM EDT
It was very difficult to make money in Q1 trading healthcare or biotech ETFs because of the sharp rally in other sectors. Nonetheless, there were two big winners.
In this article: REGN, VRTX, IBB Also: BMY, LLY, MRK, PFE, GILD, ABBV, XBI, XLV
Read
Stock Market Forecast: Stocks May Drop Further As Rates Rise
Article By: Michael J. Kramer
Sunday, February 26, 2023 2:20 PM EDT
This week will be full of economic insights, but the big data will be the ISM manufacturing and services indexes. However, I think these two reports are unlikely to do much to reverse the current trend of rising rates and a stronger dollar.
In this article: IBB, ADBE, FDN, LQD, SPY, TLT Also: UUP
Read
Tuesday Talk: My Sweet CPI
Article By: TalkMarkets DailyTalk
Tuesday, February 14, 2023 4:00 AM EDT
The street is hoping for sweet January CPI data today and that anticipation pushed stocks higher on Monday.
In this article: IBB, XLV, PLTR, BITCOMP Also: F, AAPL, TSLA, LLY, AMGN, ABBV
Read

Latest Tweets for $IBB

No tweets yet!

PARTNER HEADLINES